Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

OBJECTIVE: To compare total medical costs and utilization over a 12-month period in commercially insured patients receiving FDA-approved adjunctive atypical antipsychotics (aripiprazole, olanzapine, or quetiapine) for depression. METHODS: A retrospective claims analysis was conducted from 2005–2010...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nadkarni, Anagha, Kalsekar, Iftekhar, You, Min, Forbes, Robert, Hebden, Tony
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553650/
https://ncbi.nlm.nih.gov/pubmed/23378778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S36526
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars